Related Experiment Videos
Current systemic therapies for psoriasis: where are we now?
Paul S Yamauchi1, Dalia Rizk, Tanya Kormeili
1Clinical Research Specialists, UCLA School of Medicine, 2001 Santa Monica Boulevard, Santa Monica, CA 90404, USA.
Journal of the American Academy of Dermatology
|August 2, 2003
Summary
Systemic agents effectively manage psoriasis and improve patient quality of life. Careful patient selection and monitoring minimize adverse effects, making these treatments safer.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Systemic agents are crucial for managing moderate to severe psoriasis.
- These treatments significantly improve patient quality of life.
- Combination therapy is often used to enhance treatment efficacy.
Purpose of the Study:
- To review the role of systemic agents in psoriasis treatment.
- To discuss the benefits and risks associated with these therapies.
- To highlight strategies for safe and effective prescribing.
Main Methods:
- Literature review of systemic psoriasis treatments.
- Analysis of efficacy and adverse effect profiles.
- Discussion of patient selection and monitoring protocols.
Main Results:
- Systemic agents offer substantial psoriasis control for most patients.
- Improved quality of life indices are consistently reported.
- Adverse effects are a concern but manageable with proper protocols.
Conclusions:
- Systemic therapies are valuable in psoriasis management.
- Risk mitigation is achievable through careful patient selection and monitoring.
- Optimizing treatment requires balancing efficacy with safety.